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PREFACE 
Congenital cleft is the most common congenital craniofacial defonnity of newborn. Cleft 
lip with or without cleft palate (CLIP) is among the most common of all major birth 
defects, occurring with an incidence of 1/500 to 1/2500 in different populations, varying 
with geographic location, ethnic group, and socioeconomic conditions. It is generally 
considered that about 70% of cases of CLIP occur as an isolated abnormality, sOo-called 
"nonsyndromic" CLIP (nsCL/P). The rest occur as part of more than 300 different mUltiple 
malformation syndromes in which CLIP is but one manifestation (Jones, 1998). The 
situation regarding CP is less clear. Most studies have suggested that about 80 to 85% of 
CP cases are nonsyndromic (nsCP) (Christensen et al., 1996) (Natsume et al., 2001). 
However, one recent study from Japan found that about 80% of cases of CP are associated 
with other birth defects (Nazer et al., 2001), and most clinicians have come to suspect that 
the great majority of CP cases are, in fact, syndromic. 
Orofacial clefts are of two principal types, cleft lip (CL) and cleft palate (CP). Cleft lip is a 
unilateral or bilateral gap in the upper lip and jaw, which form during the third through 
seventh week of embryonic development. Cleft palate is a gap in the hard or soft palate, 
which forms from the fifth through twelfth weeks of development. Thus, the embryology of 
CL and CP is largely distinct, a fact that has considerable significance for the nosology of 
these two types of clefts. Cleft lip may occur either in association with or without CP, and 
hence is commonly referred to as "cleft lip with or without cleft palate" (CLIP), as distinct 
from CP, which typically occurs without associated CL. It is unclear whether CP occurring 
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In association with CL results from mechanical deformation or from genes or 
environmental factors that affect development of both the lip and palate. 
Current trend of studies in cleft are towards the genetic factor. In non-syndromic cleft 
deformity, a few genetic factors have been associated with the incidence of the cleft lip 
and/or palate. The genetic factors can either be signaling factors such as transforming 
growth factors (alpha or beta), retinoic acid, endothelin, etc or target genes such as Hox 
family, MSX genes, Pax genes etc. 
Among the target genes, MSXl gene produced the most consistent result with the incidence 
ofnon-syndromic cleft lip and/or palate. The MSXl homeobox gene is expressed at diverse 
site of epithelial- mesenchymal interaction during vertebrate embryogenesis and has a 
critical role during craniofacial bone and tooth development. Satokata and Mass in 1994 
demonstrated that mice with the MSX 1 phenotype developed cleft and oligodontia. 
The objective of this project is to determine the association between MSXl and various 
types of non-syndromic cleft lip and/or palate in Kelantanese population. With this effort 
we will determine the allele frequency of the loci on MSXl gene in the population studied. 
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ABSTRAK 
Rekahan orofasial adalah kecacatan struktur bibir dan lelangit yang melibatkan eli antara 1 
dalam 2000 sehingga 1 dalam 500 kelahiran. Di Kelantan ianya melibatkan 1 dalam 600 
kelahiran. Gen MSX 1 ialah salah satu gen sasaran dimana ia menghasilkan keputusan yang 
konsisten dalam insiden kecacatan bibir dan lelangit bukan sindrom. Gen ini terletak pada 
kromosom 4 pada lengan pendek, p 16.3-p 16.1. Ia mengandungi dua ekson yang 
mengkodkan homeodomain yang mempunyai protein dengan 297 asid amino and satu 
intron. 
Tiga puluh lima pesakit kecacatan bibir dan lelangit bukan sindrom dan 35 sampel darah 
kawalan adalah termasuk di dalam kajian ini. Mutasi pada gen MSXl telah berjaya 
dikenalpasti pada intron gen ini menggunakan pemula MSXI-CA penanda daripada 
Stegman et af. (1999). Pemula ini memperbanyakkan 9 CA ulangan dan menghasilkan 169 
pasangan bes dengan menggunakan tindakbalas rantai polimerase (PCR). Apabila produk 
daripada tindakbalas rantai polimerase telah diperolehi, gen ini akan melalui proses 
elektroforesis untuk mengesan mutasi dengan memperolehi dua jalur. Ini menunjukkan CA 
ulangan telah memanjang atau memendek daripada 9 ulangan untuk gen mutasi. 
Daripada tiga puluh lima pesakit yang diuji, lima (2%) menunjukkan variasi daripada yang 
lain manakala tujuh (31.4%) menunjukkan variasi pada lokus tertentu daripada sampel 
kawalan. Nilai P= 0.275 menunjukkan tiada perkaitan diantara mutasi pada gen MSXl dan 
x 
kecacatan bibir dan lelangit. Akan tetapi saiz sampel adalah terhad. Saiz sampel yang lebih 
besar adalah diperJukan untuk kajian masa hadapan. 
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ABSTRACT 
Orofacial cleft are congenital structural abnonnalities of the lip and/or palate that affect 
between 1 in 2000 and 1 in 500 live births worldwide. In Kelantan, it affects 1 in 600 live 
births. MSXl gene is one of the target genes which produce the most consistent result with 
the incidence of non-syndromic cleft lip and/or palate. This gene is located in chromosome 
4 at short ann, p16.3-p16.1. It has two exons that code for a homeodomain-containing 
protein of 297 amino acids and one intron. 
Thirty-five patients with non-syndromic cleft lips and lor palate and 35 control blood 
samples were included in this study. The mutation of MSXl gene has successfully been 
detected in the intron of this gene using MSXI-CA. This primer amplified nine CA repeats 
and produced 169 base pair using polymerase chain reaction (PCR). After amplification, 
the product was electrophorosed to detect the mutation by getting two bands. This showed 
the CA repeat was expanded to more or less than nine repeats for mutated gene. 
Out of thirty-five patients tested, five (2%) showed variation from the others while seven 
(31.4%) showed variation in particular locus from control samples. There was no 
association between MSXl gene mutation and clefting (P=O.275). But the sample size is 
rather limited. Larger sample size is needed for future studies. 
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1. INTRODUCTION 
1.1 Non-syndromic cleft lip and/or palate 
A cleft lip is a separation of the two sides of the lip. The separation often includes the bones 
of the upper jaw and/or upper gum. A cleft palate is an opening in the roof of the mouth in 
which the two sides of the palate did not fuse, or join together, as the unborn baby was 
developing. Cleft lip and cleft palate can occur on one side (unilateral cleft lip and/or 
palate), or on both sides (bilateral cleft lip and/or palate) (Figure I. I and Figure 1.2). 
Because the lip and the palate develop separately, it is possible for the child to have a cleft 
lip, a cleft palate, or both cleft lip and cleft palate. 
Cleft lip and cleft palate are congenital defects, or birth defects, which occur very early in 
pregnancy. The majority of clefts appear to be due to a combination of genetics and 
environmental factors (http://www.cleftline.orgfaboutcl). The ri sks of recurrence of a cleft 
condition are dependent upon many factors, including the number of affected persons in the 
family, the closeness of affected relatives, the race and sex of all affected persons, and the 
severity of the clefts (http://www.cleftline.orgfaboutcl) . 
Cleft lip and/or palate can occur in syndromic or non-syndromic form. A syndrome is a 
group of small abnormalities that are often seen together in children of unusual appearance, 
giving them a resemblance or "family ai r". (http://www.cleft .ie/publicationsO.So. cleft lip 
and/or palate are often associated wi th other abnormalities, forming part of several 
syndromes in a person of otherwise normal appearance. In some of the syndromes where 
cleft lip and/or palate are seen, the other abnormalities may be obvious and more 
threatening, as in the case of some chromosomal syndromes. "Pure form", i.e. 
unaccompanied by any other malformation is called non-syndromic cleft lip with or without 
cleft palate (http://www.cleft.ie/publications/clapabooklet/genetic.htm ). 
The human embryo has a recognisable face at around eight weeks, when it measures 28 mm 
from head to rump (http://www.cleft.ie/publications/clapabooklet/genetic.htm). At this 
stage the nose and lips have already been formed, probably as a result of cells migrating 
from the direction of the forehead and cheeks into the face. The primary palate is formed at 
the end of week seven, and results from growth from the inner sides of the upper jaw 
towards the midline, and their subsequent fusion. Fusion proceeds from front to back and is 
not completed until the 11 th week. The primary deformity in clefting of lip or palate 







CI~ssification gf tlah palate only 
A ~~ 
A. Normal palate B. Soft palate cleft c. Soft & hard palate 
Clas!ilitation of combined lip and palate 
cleft 
A. Right unilateral cleft B. Left unilateral cleft C. Bilateral cleft 
Figure 1.1 Classification of cleft lip and palate. 
Figure obtained from http://www.cleft.ie/publications/clapa_booldet/intro.htm. 
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Figure 1.2 Examples ofunrepaired facial clefts: (a) unilateral cleft lip only; (b) unilateral 
cleft lip and palate; (c)bilateral cleft lip and palate; (d) Van der Woude syndrome with a 
lower lip pit and bilateral cleft lip and palate. 
This figure obtained from Murray Je., (2002) 
1.2 MSXl gene 
Satokata and Maas (1994) found that transgenic mice rendered homozygous for a 
nonfunctioning Msxl gene showed cleft palate and facial and dental abnonnalities. Thus, 
Msxl is a candidate gene for human cleft palate. 
1.2.1. Mapping 
Ivens et al., (1990) found that the gene maps to 4pI6.1, slightly proximal to the Huntington 
Disease (lID) locus. This region shows homology of synteny with part of mouse 
chromosome 5 where the murine HOX7 gene is "located (Robert et al., 1989). Figure 1.3 
showed an idiogram ofMSXl gene. 
1.2.2. MSXl gene function 
Targeted inactivation of Msxl in transgenic mice leads to an arrest of tooth development at 
the bud stage. These mice exhibit also other developmental defects, e.g. cleft palate 
(Satokata et al., 1994). If also the MSX2 gene is rendered inactive ("double knockout"), the 
tooth development is arrested even earlier, at the initiation stage. 
There is also evidence of involvement of human MSXl in tooth development. A single 
point mutation in the homeodomain of MSXI was found to segregate with oligodontia 















Figure 1.3: Ideogram ofMSXI gene 
This figure was obtained from http://www.ncbi.nlm.nih.gov!mapview!maps.cgi 
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Most affected members also lacked some other teeth (first permanent and molars, the lack 
of which is very uncommon, or first incisors). However, the affected members of the family 
were all reported to have complete deciduous dentition, a state that would be in accordance 
with the lack of defects in heterozygous mice. Functional analysis later showed that the 
point mutation causes structural perturbation and reduced thermostability of the MSXl 
protein, thus suggesting that the phenotype is caused by smaller amount of the functional 
protein (haploinsufficiency, Hu et al., 1998). The selective effect on only certain human 
teeth of the single amino acid change in a protein that appears to be present in all teeth can 
best be interpreted in terms of an existing threshold in some point of the development that 
must be overcome to produce a complete tooth. 
MSXl has also been implicated with oral clefting. The homozygous null mutant mice 
exhibit cleft palate (Satokata et al., 1994). A polymorphism in MSXl was associated with 
clefting (Lidral et al., 1998), and recently several alterations in MSXl were found in a wide 
study of oral cleft patients (Jezewski et al., 2003). Different types of clefts were also found 
in some patients in one of the families with a MSXl exon 1 nonsense mutation (van den 
Boogaard et al., 2000). However, oral clefts were not seen in patients with heterozygous 
MSXl deletions (Nieminen et al., 2003). 
Odelberg et al., (2000) presented evidence that terminally differentiated murine myotubes 
can be induced to dedifferentiate. Ectopic expression of MSXl in C2C12 myotubes 
reduced the nuclear muscle proteins MyoD myogenin (MyoG; Mrf4 and p21 to 
undetectable levels in 20 to 50% of the myotubes. Approximately 9% of the myotubes 
cleaved to produce either smaller multinucleated myotubes or proliferating, mononucleated 
cells. Clonal populations of the myotube-derived mononucleated cells could be induced to 
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redifferentiate into cells expressing chondrogenic, adipogenic, myogenic, and osteogenic 
markers. These results suggested that tenninally differentiated mammalian myotubes can 
dedifferentiate when stimulated with the appropriate signals and that MSXl can contribute 
to the dedifferentiation process. 
BIin-Wakkach et al., (2001) demonstrated the presence of an endogenous MSXl antisense 
RNA in mice, rats, and humans. In situ analysis revealed that this RNA is expressed only in 
differentiated dental and bone cells with an inverse correlation with MSXl protein. These 
in vivo data and overexpression of MSX 1 sense and antisense RNA in an odontoblastic cell 
line showed that the balance between the levels of the two MSXI RNAs is related to the 
expression of MSXI protein. To analyze the impact of this balance in the MSX-DLX 
homeoprotein pathway, Blin-Wakkach et al., (2001) analyzed the effect of MSXI, MSX2, 
and DLX5 overexpression on proteins involved in skeletal differentiation. They showed 
that the MSXl antisense RNAs is involved in crosstalk between the MSX-DLX pathways 
because its expression was abolished by DLX5. MSXl was shown to downregulate a 
master gene of skeletal cell differentiation, Cbfal. All these data were interpreted as 
strongly suggesting that the ratio between MSXl sense and antisense RNAs is an important 
factor in the control of skeletal tenninal differentiation. The initiation site for MSXl 
antisense RNA transcription was located by primer extension in both mouse and human in 
an identical region, including a consensus TAT A box, suggesting evolutionary conservation 
of the antisense RNA-mediated regulation of MSXI gene expression. 
By investigating MSXl function in repression of myogenic gene expression, Lee et al., 
(2004) identified a physical interaction between MSXI and HIB, and found that MSXl and 
HIB bind to a key regulatory element of MYOD, a central regulator of skeletal muscle 
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differentiation, where they induce repressed chromatin. Moreover, MSXl and HIB 
cooperated to inhibit muscle differentiation in cell culture and in Xenopus animal caps. Lee 
et al., (2004) concluded that their findings defined a theretofore unknown function for 
linker histones in gene-specific transcriptional regulation. 
1.3 Polymerase chain reaction (peR) 
Polymerase chain reaction (PCR) is an in vitro technique that is commonly used for 
amplification of specific deoxyribonucleic acid (DNA) region that lies between two regions 
of known DNA sequence. PCR rapidly amplifies a single DNA molecule into many billions 
of molecules. There are three major steps in a PCR, which are repeated for 30 or 40 cycles. 
This is done on an automated cycler, which can heat and cool the tubes with the reaction 
mixture in a very short time. 
The starting material for peR, the target sequence, is a gene or segment of DNA. 
Complementary strands of double-stranded molecule of DNA are separated or denatured by 
heating. Two smaIl pieces of synthetic DNA each complimenting a specific sequence at 
opposite ends of the target sequence and lie on opposite strands of DNA serve as primers. 
Each primer binds or anneal to its complimentary sequence when the reaction mixture is 
cooled to a certain temperature. Polymerase starts at each primer and copy the sequence of 
that strand. Within a short time, exact replicates of the target sequence are produced. The 
cycle of denaturation annealing and ultimately synthesis of DNA product is repeated. In 
subsequent cycle, double-stranded molecule of both the original DNA and the copies are 
separated; primers binds again to complementary sequence and the polymerase replicates 
them. At the end of many cycles, the pool is greatly enriched in the small pieces of DNA 
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that have the target sequences, and this amplified genetic infonnation is then available for 
further analysis. The product of PCR is a segment of double stranded DNA which length is 
defined by the distance between the two primers. Sets are available to perfonn PCR that 
contain the DNA polymerase, deoxyribonucleoside phosphates (dNTPs) and lOX buffers. 
There are various thennostable polymerase enzymes available commercially for use in PCR 
the most common of which are Taq DNA polymerase, obtained from Thermus aquaticus 
and Pfu DNA polymerase, obtained from Pyrococcus furiosus. The buffer solutions contain 
potassium chloride (KCI) and magnesium chloride for Taq DNA polymerase and KCI and 
magnesium sulphate (MgS04) for Pfu DNA polymerase. Divalent cations are very 
important for the proper function of DNA polymerase enzymes. Figure 1.4 shows the 
diagram depicting the PCR process. 
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